Basilea Pharmaceutica (BSLN) is a Swiss biopharmaceutical company, founded in 2000 and located in Basel, Switzerland. The company discovers, develops and commercialises innovative pharmaceutical products for fungal and bacterial infections, as well as cancer. Basilea Pharmaceutica owns such brands as Zevtera/Mabelio, Cresemba and Toctino. Since 2004, Basilea Pharmaceutica has been listed on the SIX Swiss Exchange. Follow the Basilea Pharma share price (BSLN) at Capital.com.